7146
I. Okamoto et al. / Tetrahedron Letters 47 (2006) 7143–7146
K. Tetrahedron Lett. 1996, 37, 5003–5006; (c) Azumaya, I.;
at 0 °C, and ethyl chloroformate (5.00 mmol) was added,
followed by stirring for 1 h. To this mixture, 2-(methyl-
amino)pyridine (5.00 mmol) was added, and the resulting
mixture was stirred at ambient temperature for 3 h, then
filtrated. The solvent was removed by evaporation, and
the resulting mixture was flash-chromatographed to afford
the desired amide. Compound 2: Mp 77.5 °C; 1H NMR
(300 MHz, CDCl3) d 8.30 (m, 2H), 7.71 (m, 2H), 7.54 (dt,
J = 1.9, 7.8 Hz, 1H), 7.20 (m, 1H), 7.03 (m, 2H), 3.61 (s,
3H). Anal. Calcd for C12H11N3O: C, 67.59; H, 5.20; N,
19.71. Found: C, 67.51; H, 5.22; N, 19.52. Compound 3:
Okamoto, I.; Nakayama, S.; Tanatani, A.; Yamaguchi,
K.; Shudo, K.; Kagechika, H. Tetrahedron 1999, 55,
11237–11246; (d) Tanatani, A.; Yokoyama, A.; Azumaya,
I.; Takakura, Y.; Mitsui, C.; Shiro, M.; Uchiyama, M.;
Muranaka, A.; Kobayashi, N.; Yokozawa, T. J. Am.
Chem. Soc. 2005, 127, 8553–8561.
5. Betson, M. S.; Clayden, J.; Lam, H. K.; Helliwell, M.
Angew. Chem., Int. Ed. 2005, 44, 1241–1244.
6. (a) Clayden, J.; Lund, A.; Vallverdu, L.; Helliwell, M.
Nature 2004, 431, 966–971; (b) Kern, D.; Zuiderweg, E. R.
P. Curr. Opin. Struct. Biol. 2003, 13, 748–757; (c) Seebach,
D.; Schreiber, J. V.; Abele, S.; Daura, X.; van Gunsteren,
W. F. Helv. Chim. Acta 2000, 83, 34–57.
7. (a) Hofacker, A. L.; Parquette, J. R. Angew. Chem., Int.
Ed. 2005, 44, 1053–1057; (b) Yue, N. L. S.; Jennings, M.
C.; Puddephatt, R. J. Inorg. Chem. 2005, 44, 1125–1131;
(c) Heemstra, J. M.; Moore, J. S. Chem. Commun. 2004,
1480–1481; (d) Chatterjee, B.; Noveron, J. C.; Resendiz,
M. J. E.; Liu, J.; Yamamoto, T.; Parker, D.; Cinke, M.;
Nguyen, C. V.; Arif, A. M.; Stang, P. J. J. Am. Chem. Soc.
2004, 126, 10645–10656; (e) Crabtree, R. H.; Siegbahn, P.
E. M.; Eisenstein, O.; Rheingold, A. L.; Koetzle, T. F.
Acc. Chem. Res. 1996, 29, 348–354; (f) Fujita, M.; Oguro,
D.; Miyazawa, M.; Oka, H.; Yamaguchi, K.; Ogura, K.
Nature 1995, 378, 469–471.
8. (a) Perlepes, S. P.; Kabanos, T.; Hondrellis, V.; Tsangaris,
J. M. Inorg. Chim. Acta 1988, 150, 13–23; (b) Bould, J.;
Brisdon, B. J. Inorg. Chim. Acta 1976, 19, 159–163; (c)
Brown, R. F. C.; Radom, L.; Sternhell, S.; Rae, I. D. Can.
J. Chem. 1968, 46, 2577–2587.
9. Acceptor number and donor number are empirical
parameters describing electrophilic behavior and nucleo-
philic behavior of solvents, respectively: (a) Gutmann, V.
The Donor–Acceptor Approach to Molecular Interactions;
Plenum Press: New York, 1978; (b) Gutmann, V. Elec-
trochim. Acta 1976, 21, 661–670.
10. Chief CRC Handbook of Chemistry and Physics, 71st ed.;
Lide, D. R., Ed.; CRC Press: Boston, 1990; Vols. 1990–
1991.
11. (a) Linert, W.; Jameson, R. F. J. Chem. Soc., Perkin
Trans. 2 1993, 1415–1421; (b) Dimroth, K.; Reichardt, C.;
Siepmann, T.; Bohlmann, F. Liebigs Ann. Chem. 1963,
661, 1–37.
12. (a) Azumaya, I. Yakugaku Zasshi 2001, 121, 117–129; (b)
Azumaya, I.; Yamaguchi, K.; Kagechika, H.; Saito, S.;
Itai, A.; Shudo, K. Yakugaku Zasshi 1994, 114, 414–430.
13. Cis:trans conformational ratios of 2 at 183 K in CD2Cl2,
toluene-d8, and THF-d8 were 96:4, 91:9, and 93:7, respec-
tively. In the case of this simple amide 2, solvent-induced
conformational switching cannot be observed.
14. General procedure for the synthesis of amides is as follows:
A solution of pyridinecarboxylic acid (5.00 mmol) and
triethylamine (10.0 mmol) in tetrahydrofuran was stirred
1
Mp 141.0–142.5 °C; H NMR (300 MHz, CDCl3) d 8.49
(m, 2H), 8.17 (dd, J = 1.2, 4.9 Hz, 1H), 7.91 (dd, J = 2.2,
5.1 Hz, 1H), 7.64 (dt, J = 1.9, 7.8 Hz, 1H), 7.13 (d,
J = 8.1 Hz, 1H), 7.06 (ddd, J = 0.9, 4.9, 7.3 Hz, 1H),
3.63 (s, 3H). Anal. Calcd for C12H10N4O3: C, 55.81; H,
3.90; N, 21.70. Found: C, 55.69; H, 3.62; N, 21.91.
Compound 4: Mp 104.0–105.5 °C; 1H NMR (300 MHz,
CDCl3) d 8.27 (d, J = 5.0 Hz, 1H), 7.73 (dd, J = 0.9,
7.7 Hz, 1H), 7.65 (dt, J = 1.9, 7.8 Hz, 1H), 7.57 (t,
J = 7.7 Hz, 1H), 7.37 (d, J = 7.9 Hz, 1H), 7.14 (br d,
J = 9.0 Hz, 1H), 7.11 (ddd, J = 0.9, 4.9, 7.4 Hz, 1H), 3.58
(s, 3H). Anal. Calcd for C12H10N3OBr: C, 49.34; H, 3.45;
N, 14.38. Found: C, 49.30; H, 3.43; N, 14.25. Compound
1
5: Mp 71.5–72.0 °C; H NMR (300 MHz, CDCl3) d 8.25
(dd, J = 1.3, 5.0 Hz, 1H), 8.02 (dd, J = 1.5, 7.6 Hz, 1H),
7.95 (dd, J = 1.4, 7.8 Hz, 1H), 7.87 (t, J = 7.7 Hz, 1H),
7.60 (dt, J = 1.7, 8.1 Hz, 1H), 7.16 (br d, J = 8.3 Hz, 1H),
7.05 (ddd, J = 0.9, 5.0, 7.5 Hz, 1H), 3.83 (s, 3H), 3.60 (s,
3H). Anal. Calcd for C14H13N3O3: C, 61.99; H, 4.83; N,
15.49. Found: C, 61.91; H, 4.92; N, 15.59. Compound 6:
1
Mp 145.0–146.0 °C; H NMR (300 MHz, CDCl3) d 8.92
(ddd, J = 0.9, 1.6, 4.7 Hz, 1H), 7.55 (dt, J = 1.7, 7.8 Hz,
1H), 7.36 (d, J = 6.8 Hz, 1H), 7.27 (t, J = 7.9 Hz, 1H),
7.02 (m, 2H), 6.85 (1H, J = 7.9 Hz,1H), 3.09 (s, 3H). Anal.
Calcd for C12H10N3OBr: C, 49.34; H, 3.45; N, 14.38.
Found: C, 49.30; H, 3.45; N, 14.43. Compound 7: Mp
1
140.0–140.5 °C; H NMR (300 MHz, CDCl3) d 8.31 (m,
2H), 7.73 (ddd, J = 0.4, 1.8, 7.6 Hz, 2H), 7.60 (m, 2H),
7.39 (t, J = 7.9 Hz, 1H), 7.24 (ddd, J = 1.3, 5.0, 7.7 Hz,
2H), 6.75 (d, J = 7.9 Hz, 2H), 3.23 (s, 6H). Anal. Calcd for
C19H17N5O2: C, 65.69; H, 4.93; N, 20.16. Found: C, 66.07;
H, 4.94; N, 20.19. Compound 8: Mp 113 °C; 1H NMR
(300 MHz, CDCl3) d 8.25 (ddd, J = 0.9, 2.0, 4.8 Hz, 2H),
7.75 (dd, J = 7.3, 8.2 Hz, 1H), 7.58 (m, 2H), 7.56 (m, 2H),
7.04 (ddd, J = 1.0, 4.9, 7.4 Hz, 2H), 7.00 (m, 2H), 3.33 (s,
6H). Anal. Calcd for C19H17N5O2: C, 65.69; H, 4.93; N,
20.16. Found: C, 65.83; H, 4.86; N, 20.23. Compound 9:
1
Mp 140.0–141.0 °C; H NMR (300 MHz, CDCl3) d 8.39
(ddd, J = 0.7, 2.0, 4.9 Hz, 2H), 8.35 (d, J = 2.2 Hz, 2H),
7.76 (t, J = 2.0 Hz, 1H), 7.56 (dt, J = 1.8, 7.7 Hz, 2H),
7.12 (ddd, J = 0.9, 4.9, 7.5 Hz, 2H), 6.85 (br d, J = 8.1 Hz,
2H), 3.54 (s, 6H). Anal. Calcd for C19H17N5O2: C, 65.69;
H, 4.93; N, 20.16. Found: C, 65.70; H, 4.74; N, 20.10.